Evidence map›Paper›PMID 39165919›Full record

ArticleFrontiers in cellular and infection microbiology2024

Application of metagenomic next-generation sequencing and targeted metagenomic next-generation sequencing in diagnosing pulmonary infections in immunocompetent and immunocompromised patients.

Yong Liu, Wencai Wu, Yunping Xiao, Hongyan Zou, Sijia Hao, Yanfang Jiang

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Nucleic Acid Amplification Tests forPathogens (Basel, Switzerland) · 2026
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Characteristics of CD4Journal of intensive medicine · 2026
    Article
  8. Article
  9. Article
  10. Clinical characteristics ofFrontiers in cellular and infection microbiology · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Molecular analysis of carbapenem-resistantFrontiers in cellular and infection microbiology · 2026
    Article
  18. Article
  19. Clinical Features and Diagnostic Challenges ofInfection and drug resistance · 2026
    Article
  20. Advances in pathogen detection ofInfectious medicine · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yong LiuGenetic Diagnosis Center, The First Hospital of Jilin University, Changchun, China.
Wencai WuKey Laboratory of Biomedical Information Engineering of Ministry of Education, Biomedical Informatics & Genomics Center, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Yunping XiaoGenetic Diagnosis Center, The First Hospital of Jilin University, Changchun, China.
Hongyan ZouGenetic Diagnosis Center, The First Hospital of Jilin University, Changchun, China.
Sijia HaoGenetic Diagnosis Center, The First Hospital of Jilin University, Changchun, China.
Yanfang JiangGenetic Diagnosis Center, The First Hospital of Jilin University, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Metagenomic next-generation sequencing (mNGS) technology has been widely used to diagnose various infections. Based on the most common pathogen profiles, targeted mNGS (tNGS) using multiplex PCR has been developed to detect pathogens with predesigned primers in the panel, significantly improving sensitivity and reducing economic burden on patients. However, there are few studies on summarizing pathogen profiles of pulmonary infections in immunocompetent and immunocompromised patients in Jilin Province of China on large scale. Methods: From January 2021 to December 2023, bronchoalveolar lavage fluid (BALF) or sputum samples from 546 immunocompetent and immunocompromised patients with suspected community-acquired pneumonia were collected. Pathogen profiles in those patients on whom mNGS was performed were summarized. Additionally, we also evaluated the performance of tNGS in diagnosing pulmonary infections. Results: Combined with results of mNGS and culture, we found that the most common bacterial pathogens were Conclusions: Our findings supplemented and classified the pathogen profiles of pulmonary infections in immunocompetent and immunocompromised patients in Jilin Province of China. Most importantly, our findings can accelerate the development and design of tNGS specifically used for regional pulmonary infections.

Indexed as

Bronchoalveolar Lavage FluidHigh-Throughput Nucleotide SequencingImmunocompromised HostMetagenomicsAdolescentAdultAgedAged, 80 and overBacteriaChinaCommunity-Acquired InfectionsFemaleHumansImmunocompetenceMaleMiddle Agedbronchoalveolar lavage fluidimmunocompetent and immunocompromisedMNGspulmonary infectionTNGS

Identifiers

PMID39165919
PMCPMC11333343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.